Survival advantage by female sex is additionally maintained
among elderly patient population. during a population-based
analysis from the seer database, eighteen, 967 elderly patients
( 65 years previous ) with stage i and that ii nsclc, diagnosed
between 1991 and 1999, were thought-about. patients were
grouped into 3 categories consistent with the treatment
received : operation, radiation or chemotherapy, and untreated
cases. survival knowledge were controlled for competing risks,
together with lung cancer– specific survival, overall survival adjusting
for comorbidities, and relative survival. ladies in
all treatment teams had higher lung cancer–specific, overall,
and relative survival than men ( p . 0001 ), and this benefit
was retained with multivariate analysis. sensitivity analyses
demonstrated that these survival differences were not related
to a unique smoking behavior. sex differences were too observed
among untreated patients, and this could recommend that
lung cancer in ladies has a diffe rent natural history. 125 an
ongoing south western oncology cluster ( swog ) trial is
investigating molecular epidemiology of nsclc in smoking
and never-smoking men and ladies, evaluating the influence
of hormonal and reproductive factors in 720 stage i to
iii lung cancer patients.
the epidemiological findings from population-based
studies indicate that a lot of ladies are diagnosed at earlier
stages. the next adherence rate among ladies in ongoing early
detection studies raises the issue of whether or not or not the survival
advantage by sex could be attributable no more than to a a lot of frequent
medical consultation and radiological assessment instead of
connected to differences in genetic predisposition and natural history
of the neoplastic disease.
as previously described, the elcap screening project gave
insights into ladies and lung cancer. 51 within the international early
lung cancer action program ( i-elcap ), fourteen, 435 asymptomatic
volunteers with no previous history of cancer and fit to undergo
thoracic operation ( 6296 ladies ), a minimum of forty years of age, and past
or current cigarette smokers underwent baseline ct screening for
lung cancer. lung cancer was diagnosed in 111 of 6296 women
and 93 of 8139 men : in terms of prevalence, the ladies-to-men
or was one. half dozen ( p . 001 ). ladies diagnosed with lung cancer
were at a comparable age to men ( 67 vs. 68 years ) other then had a
considerably reduced tobacco exposure ( 47 vs. 64 pack-years, respectively ).
additionally, ladies were a lot of frequently diagnosed
in clinical stage i disease ( 89% vs. 80% ), other then the resection rate
in stage i used to be no more than slightly higher than men ( 90% vs. 88% ). the
proportion of adenocarcinoma subtype among ladies and men
was 73% versus 59%, respectively. 126
from this study, the hypothesis that ladies could be more
susceptible to tobacco carcinogens seems biologically plausible :
if lung cancer risk for girls who smoke is indeed higher
than the risk on behalf of men of constant age who smoke, this suggests
that antismoking efforts directed toward ladies and ladies need
to be even a lot of serious than those directed toward boys and
men. for constant reason, in consideration that early detection
programs are conducted among smokers, female sex imply
screening at lower levels of tobacco exposure than the corresponding
indication threshold in men.
overall, the proof suggests that ladies with lung cancer
survive longer than men which this distinction is more
pronounced in terribly early stages. cancer stage at diagnosis,
cell type, or treatment don't seem to be entirely explanatory
of this distinction, and that it isn't clear whether or not this survival
distinction is as a result of lung cancer in ladies tends to be more
commonly curable or less malignant.
among elderly patient population. during a population-based
analysis from the seer database, eighteen, 967 elderly patients
( 65 years previous ) with stage i and that ii nsclc, diagnosed
between 1991 and 1999, were thought-about. patients were
grouped into 3 categories consistent with the treatment
received : operation, radiation or chemotherapy, and untreated
cases. survival knowledge were controlled for competing risks,
together with lung cancer– specific survival, overall survival adjusting
for comorbidities, and relative survival. ladies in
all treatment teams had higher lung cancer–specific, overall,
and relative survival than men ( p . 0001 ), and this benefit
was retained with multivariate analysis. sensitivity analyses
demonstrated that these survival differences were not related
to a unique smoking behavior. sex differences were too observed
among untreated patients, and this could recommend that
lung cancer in ladies has a diffe rent natural history. 125 an
ongoing south western oncology cluster ( swog ) trial is
investigating molecular epidemiology of nsclc in smoking
and never-smoking men and ladies, evaluating the influence
of hormonal and reproductive factors in 720 stage i to
iii lung cancer patients.
the epidemiological findings from population-based
studies indicate that a lot of ladies are diagnosed at earlier
stages. the next adherence rate among ladies in ongoing early
detection studies raises the issue of whether or not or not the survival
advantage by sex could be attributable no more than to a a lot of frequent
medical consultation and radiological assessment instead of
connected to differences in genetic predisposition and natural history
of the neoplastic disease.
as previously described, the elcap screening project gave
insights into ladies and lung cancer. 51 within the international early
lung cancer action program ( i-elcap ), fourteen, 435 asymptomatic
volunteers with no previous history of cancer and fit to undergo
thoracic operation ( 6296 ladies ), a minimum of forty years of age, and past
or current cigarette smokers underwent baseline ct screening for
lung cancer. lung cancer was diagnosed in 111 of 6296 women
and 93 of 8139 men : in terms of prevalence, the ladies-to-men
or was one. half dozen ( p . 001 ). ladies diagnosed with lung cancer
were at a comparable age to men ( 67 vs. 68 years ) other then had a
considerably reduced tobacco exposure ( 47 vs. 64 pack-years, respectively ).
additionally, ladies were a lot of frequently diagnosed
in clinical stage i disease ( 89% vs. 80% ), other then the resection rate
in stage i used to be no more than slightly higher than men ( 90% vs. 88% ). the
proportion of adenocarcinoma subtype among ladies and men
was 73% versus 59%, respectively. 126
from this study, the hypothesis that ladies could be more
susceptible to tobacco carcinogens seems biologically plausible :
if lung cancer risk for girls who smoke is indeed higher
than the risk on behalf of men of constant age who smoke, this suggests
that antismoking efforts directed toward ladies and ladies need
to be even a lot of serious than those directed toward boys and
men. for constant reason, in consideration that early detection
programs are conducted among smokers, female sex imply
screening at lower levels of tobacco exposure than the corresponding
indication threshold in men.
overall, the proof suggests that ladies with lung cancer
survive longer than men which this distinction is more
pronounced in terribly early stages. cancer stage at diagnosis,
cell type, or treatment don't seem to be entirely explanatory
of this distinction, and that it isn't clear whether or not this survival
distinction is as a result of lung cancer in ladies tends to be more
commonly curable or less malignant.
0 komentar:
Posting Komentar